Comparison of efficacy and safety of shockwave lithotripsy for upper urinary tract stones of different locations in children: a study of 311 cases

2010 ◽  
Vol 29 (6) ◽  
pp. 713-717 ◽  
Author(s):  
Lei He ◽  
Xizhao Sun ◽  
Jianlin Lu ◽  
Xiaoming Cong ◽  
Huaijun Zhu ◽  
...  
2005 ◽  
Vol 19 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Sergey Kravchick ◽  
Igor Bunkin ◽  
Eugeny Stepnov ◽  
Ronit Peled ◽  
Leonid Agulansky ◽  
...  

2005 ◽  
Vol 19 (7) ◽  
pp. 768-773 ◽  
Author(s):  
Taku Abe ◽  
Koichiro Akakura ◽  
Makoto Kawaguchi ◽  
Takeshi Ueda ◽  
Tomohiko Ichikawa ◽  
...  

Urolithiasis ◽  
2018 ◽  
Vol 48 (1) ◽  
pp. 57-61 ◽  
Author(s):  
Ahmed Suliman ◽  
Tariq Burki ◽  
Massimo Garriboli ◽  
Jonathan Glass ◽  
Arash Taghizadeh

2006 ◽  
Vol 134 (1-2) ◽  
pp. 40-43
Author(s):  
Dragica Milenkovic ◽  
Natasa Lalic

The incidence of urinary tract calculosis continuously progresses. The triggering event in the process of stone formation is decreased urinary level of crystallizing inhibitors. The aim of our study was to investigate whether the existing stone or applied therapeutic procedure - extracorporeal shock waves lithotripsy (ESWL) - has effect to urinary levels of Mg, citrate and pyrophosphate. Study included 128 patients with the upper urinary tract stones. ESWL using the Lithostar (Siemens) device was used as a mode of treatment. Out of all patients, 76 (59%) were free of stone particles before 1 month, while 52 (41%) had residual stone fragments even 3 months after ESWL. Mg, citrate and pyrophosphate were measured in 24hurine specimens: before, between days 2 and 3, as well as 1 and 3 months after ESWL. The analysis of the results revealed that stone itself had no effect on urinary crystallizing inhibitors. Detected increased urinary levels of Mg, citrate and pyrophosphate after ESWL, compared with pre-treatment values, could be attributed to applied therapeutic procedure.


Sign in / Sign up

Export Citation Format

Share Document